Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) Is Down -4.78% – Is It A Buying Opportunity?

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) traded at $1.99 at close of the session on Friday, July 19, made a downward move of -4.78% on its previous day’s price.

Looking at the stock we see that its previous close was $2.09 . In terms of its 52-week price range, LXRX has a high of $3.73 and a low of $0.92. The company’s stock has gained about 13.71% over that past 30 days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Lexicon Pharmaceuticals Inc has a market cap of $719.37 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.19, with the EPS growth for the year raised at -$0.75 for 2024 and -$0.61 for next year. These figures represent 5.10% and 18.70% growth in EPS for the two years respectively.

Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $2.83 million, with a low of $1.8 million and a high of $3.4 million. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $24.11 million, or 1,902.50% up from figures reported last year.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the LXRX stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 100% Buy.

Looking further, we note the current price level is 10.39% off its SMA20 and 11.18% from its 50-day simple moving average. The RSI (14) is pointing at 56.87 while the volatility over the past week is 7.93% and jumps to 6.95% over the past one month. The beta value is 1.36, while the average true range (ATR) is currently pointing at 0.13.

Coming back to Lexicon Pharmaceuticals Inc (NASDAQ:LXRX), we note that the average 3-month trading volume was 2.69 million. Current shares outstanding are 361.49 million.

The insiders hold 2.81% of the company’s shares while institutions hold 62.74%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 30.07% up in year-to-date price movement.

Most Popular